(Q35185203)

7 August 2017

1 reference

title

Artificial oxygen carrying blood substitutes (English)

1 reference

7 August 2017

Artificial Oxygen Carrying Blood Substitutes (English)

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

24 November 2023

author name string

N. S. Faithfull

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1288172

24 November 2023

language of work or name

English

0 references

publication date

1 January 1992

1 reference

full work available at URL

7 August 2017

http://link.springer.com/content/pdf/10.1007/978-1-4615-3428-0_6.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Advances in Experimental Medicine and Biology

24 November 2023

published in

1 reference

7 August 2017

volume

317

1 reference

7 August 2017

page(s)

55-72

1 reference

Clinical experience with hemoglobin-saline solutions

7 August 2017

cites work

5

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Preparation of human hemoglobin Ao for possible use as a blood substitute

24 November 2023

8

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Evaluation of a stroma-free hemoglobin solution for use as a plasma expander

24 November 2023

11

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Hemoglobin II immunogenic properties of stroma vs. stroma-free hemoglobin solution.

24 November 2023

16

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Biomaterials, artificial cells, and artificial organs

24 November 2023

17

15

350

FJ Bruzzese

1987

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Serum antibody titers in rats receiving repeated small subcutaneous injections of hemoglobin or polyhemoglobin: a preliminary report

24 November 2023

19

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Early deleterious hemorheologic changes following acute experimental coronary occlusion and salutary antihyperviscosity effect of hemodilution with stroma-free hemoglobin

24 November 2023

21

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

The effect of altered hemoglobin-oxygen affinity on oxygen transport by hemoglobin solution

24 November 2023

24

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

A clinical safety trial of stroma-free hemoglobin

24 November 2023

25

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

RENAL EFFECTS OF HEMOGLOBIN INFUSIONS IN DOGS IN HEMORRHAGIC SHOCK

24 November 2023

27

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Ultrapure, stroma-free, polymerized bovine hemoglobin solution: evaluation of renal toxicity

24 November 2023

29

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Animal model for nephrotoxicity of haemoglobin tetramer

24 November 2023

31

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Large-volume preparation of pyridoxylated hemoglobin with high P50

24 November 2023

38

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Preparation and evaluation of pyridoxalated-polymerized human hemoglobin

24 November 2023

39

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

24 November 2023

42

4

494

RW Tye

1984

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Soluble dextran-hemoglobin complex as a potential blood substitute

24 November 2023

43

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Modification of human hemoglobin with polyethylene glycol : a new candidate for blood substitute

24 November 2023

44

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Limb preservation in replantation surgery

24 November 2023

47

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Synthesis and evaluation of a prototypal artificial red cell

24 November 2023

49

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Survival of Mammals Breathing Organic Liquids Equilibrated with Oxygen at Atmospheric Pressure

24 November 2023

50

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Fate of perfluorochemicals in animals after intravenous injection or hemodilution with their emulsions

24 November 2023

53

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Effect of perfluorochemical blood substitutes on human neutrophil function

24 November 2023

55

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Peripheral vascular responses to fluorocarbon administration

24 November 2023

56

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Cardiorespiratory consequences of fluorocarbon reactions in dogs

24 November 2023

58

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion

24 November 2023

59

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Beneficial long-term effect of intracoronary perfluorochemical on infarct size and ventricular function in a canine reperfusion model

24 November 2023

60

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA

24 November 2023

61

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Fluosol-DA as a red-cell substitute in acute anemia

24 November 2023

62

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Distal coronary artery perfusion during percutaneous transluminal coronary angioplasty

24 November 2023

64

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Preservation of left ventricular ejection fraction during percutaneous transluminal coronary angioplasty by distal transcatheter coronary perfusion of oxygenated Fluosol DA 20%.

24 November 2023

65

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol

24 November 2023

66

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Phase I/II study of Fluosol-DA and 100% oxygen as an adjuvant to radiation in the treatment of advanced squamous cell tumors of the head and neck

24 November 2023

67

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

A phase I/II study of the use of Fluosol as an adjuvant to radiation therapy in the treatment of primary high-grade brain tumors.

24 November 2023

68

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Fluosol and oxygen breathing as an adjuvant to radiation therapy in the treatment of locally advanced non-small cell carcinoma of the lung: results of a phase I/II study

24 November 2023

69

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Effect of a perfluorochemical emulsion on the radiation response of BA1112 rhabdomyosarcomas

24 November 2023

70

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Use of a perfluorochemical emulsion to improve oxygenation in a solid tumor

24 November 2023

71

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Preclinical studies of a perfluorochemical emulsion as an adjunct to radiotherapy.

24 November 2023

72

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU

24 November 2023

74

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Perfluorocarbon as blood substitute in clinical applications and in war casualties

24 November 2023

76

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

30th Anniversary in Artificial Red Blood Cell Research

24 November 2023

78

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

30th Anniversary in Artificial Red Blood Cell Research

24 November 2023

79

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

30th Anniversary in Artificial Red Blood Cell Research

24 November 2023

80

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%)

24 November 2023

81

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

New and unexpected reactivity of saturated fluorocarbons

24 November 2023

83

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Perfluorocarbon blood substitutes

24 November 2023

87

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Perfluorocarbons as oxygen-transport fluids

24 November 2023

88

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Fluorocarbons. Current status and future applications

24 November 2023

89

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Leukocyte depletion results in excellent heart-lung function after 12 hours of storage

24 November 2023

90

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Excretion of perfluorochemicals after intravenous injection of their emulsion

24 November 2023

91

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA) Summary of 186 cases

24 November 2023

94

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Liver, spleen, and vessels: preliminary clinical results of CT with perfluorooctylbromide

24 November 2023

96

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Development of a perfluorochemical emulsion as a blood gas carrier

24 November 2023

97

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Tissue oxygenation by fluorocarbons

24 November 2023

100

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

A simple method for measuring red cell deformability in models of the microcirculation

24 November 2023

101

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Effects of perfluorochemical on phagocytic function of leukocytes

24 November 2023

103

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Effect of perfluorochemical (Fluosol-DA) on infarct morphology in dogs

24 November 2023

105

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

The effects of acute ischaemia on intramyocardial oxygen tensions

24 November 2023

109

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Effects of haemodilution with fluorocarbons or dextran on oxygen tensions in the acutely ischaemic myocardium.

24 November 2023

110

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Effect of fluocarbon exchange transfusion on myocardial infarction size in dogs

24 November 2023

112

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Fluorocarbons reduce myocardial ischemic damage after coronary occlusion

24 November 2023

113

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Protective effect of Fluosol-DA in acute cerebral ischemia

24 November 2023

114

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Modification of cerebral ischemia with Fluosol

24 November 2023

115

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Experimental study of new cerebral protective substances - functional recovery of severe, incomplete ischaemic brain lesions pretreated with mannitol an fluorocarbon emulsion

24 November 2023

116

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

The protective effect of mannitol and perfluorochemicals on hemorrhagic infarction: an experimental study

24 November 2023

117

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Severe cerebral ischemia treatment by ventriculosubarachnoid perfusion with an oxygenated fluorocarbon emulsion.

24 November 2023

118

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Preservation of neuronal function during prolonged focal cerebral ischemia by ventriculocisternal perfusion with oxygenated fluorocarbon emulsion

24 November 2023

119

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Oxygenated Fluorocarbon Nutrient Solution in the Treatment of Experimental Spinal Cord Injury

24 November 2023

120

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Intestinal ischemia: reduction of mortality utilizing intraluminal perfluorochemical.

24 November 2023

123

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Biological disposition of perfluoroctylbromide: tracheal administration in alveolography and bronchography.

24 November 2023

124

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Journal of Magnetic Resonance

24 November 2023

126

36

173

J-J Delpuech

1979

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Reactive hyperemia monitored on rat muscle using perfluorocarbons and 19F NMR

24 November 2023

128

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

In situ assessment of tumor vascularity using fluorine NMR imaging

24 November 2023

129

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Experimental Comparison of EOE-13 and Perfluoroctylbromide for the CT Detection of Hepatic Metastases

24 November 2023

130

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Perfluoroctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material

24 November 2023

131

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Ultrasonic enhancement of myocardial infarction with perfluorocarbon compounds in dogs

24 November 2023

132

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Potential role of PFOB enhanced sonography of the kidney. II. Detection of partial infarction

24 November 2023

133

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Potential role of PFOB enhanced sonography of the kidney. I. Detection of renal function and acute tubular necrosis

24 November 2023

134

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Fluorochemical perfusates for renal preservation

24 November 2023

136

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Erythrocyte Substitute for Perfusion of Brain

24 November 2023

137

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Canine liver isolation-perfusion at normo- and hyperthermic temperatures with perfluorochemical emulsion (Fluosol-43).

24 November 2023

140

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

Liquid ventilation of human preterm neonates

24 November 2023

145

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3428-0_6

24 November 2023

Identifiers

0 references

1 reference